Biphasic Roles of a Small G-Protein, RAC1 in Pancreatic Β-Cell

Mayur S. Parmar, Altaf Ahmed Meer, Ismail Syed

Brain and Mind Research Institute, Weill Cornell Medical College, NY 10065, New York, USAUnited States
Department of Chemistry, Osmania College, Kurnool, AP 518001, IndiaIndia
Department of Medicine, Division of Endocrinology, Beth Israel Deaconess Medical Center, Harvard Medical School, MA 02215, Boston, USAUnited States

DOI: https://doi.org/10.17140/goj-1-114 · Published 2015-07-08 · Licence: https://creativecommons.org/licenses/by/4.0 · © 2015 The Author(s)

Also available as PDF (figures and tables appear in the PDF).

Keywords: Small G-protein; Rac; Insulin secretion; NADPH oxidase; Oxidative stress; Islets

Introduction

Diabetes is a metabolic disorder with multiple etiologies characterized by chronic hyperglycemia. This results from dysregulated insulin secretion and/or from the resistance to insulin action in peripheral tissues. In the settings of the metabolic disorder, disturbances in carbohydrate, fat and protein metabolism results in a diverse set of complications associated with pancreas, liver, kidney, heart and other vital organs. As per the National Diabetes Statistics Report, 2014, in 2012, 29.1 million Americans (2.9% of the population) have diabetes, which

decades of research, a greater understanding of the pancreatic β-cells in physiological insulin release has been made to therapeutically target and treat the metabolic disorder. Insulin secre-

messengers like reactive oxygen species (ROS), cyclic nucleotides and hydrolytic products 1-13 generated from the phospholipases A2, C and D. In addition, adenine nucleotides [e.g., ATP]

and guanine nucleotides [e.g., GTP; regulate physiological insulin secretion. Even though many studies have shown the underlying mechanism[s] involved in stimulus-secretion coupling of glucose stimulated insulin secretion (GSIS), the precise molecular and cellular mechanism still remains unknown. However, role of guanine nucleotide-binding protein (G-protein) has been highly researched for their role in insulin release. The signal-transduction system (Adenylylcyclases, ion channels, and phospholipases) involved in insulin release are linked to the receptors for hormones or stimulatory agents via G-proteins.

CLASSIFICATION OF G-PROTEINS IN β-CELL

Till date three major classes of G-proteins have been 18-22 identified in pancreatic β-cells. The first class of G-proteins, heterotrimeric G-proteins assists in coupling membrane-associated receptors to their intracellular effectors adenylyl cyclases, ion channels, and phosphodiesterases. The second class of Gproteins, small monomeric G-proteins [17-30 kDa] play a vital role in protein organization and trafficking of secretory vesicle.26 These small G-proteins undergo posttranslational modifications [isoprenylation and methylation] at their C-terminal residues 26-30 (CAAX motif) for their active confirmation. The third class of G-proteins, the elongation factors and Tau proteins are implicated in protein synthesis.

Small G-Proteins

Based on the substantial evidences on the regulation of pancreatic islet β-cell function, small G-proteins are categorized into three major groups. Rho, Rac1, Cdc42 and ADP-ribosylation factor-6 [Arf6] fall under the first category of small G-proteins and these play an important role in cytoskeletal remodeling 31-48 and vesicular fusion. The second category of small G-proteins comprises of Rap1 and RabGTPases (Rab3A and Rab27).49 These Rab GTPases assists in priming and docking of insulinladen secretory granules on the plasma membrane. Unlike first category of small G-proteins, requisite for posttranslational modifications and mechanism[s] involved in the activation of Rab GTPases under the physiological insulin secretagogues remains elusive. However, Rap1 is activated transiently by glu- 50 18,51 cose and undergoes carboxymethylation. The third group of small G-proteins consists of Rab2, Rhes and Rem2 which are 52-55 under-studied, whereas, RalA appears to draw direct regulatory effects in exocytosis. Do you have data about small Gproteins expression in pancreas?

Activation And Deactivation Cycle Of Small G-Pro- Teins

Like heterotrimeric G-proteins, small G-proteins also shuttle between their inactive (GDP-bound) and active (GTPbound) conformations, and are tightly regulated by various Gprotein regulatory factors/proteins. Till date, three regulatory factors have been identified for small G-proteins, viz., Guanine

Gastro

14-17 exchange nucleotide factors [GEFs], GDP-dissociation inhibitors [GDIs] and GTPase-activating proteins [GAPs]. GEFs facilitate the translation of the inactive GDP-bound to their active GTP-bound forms, while, the GDIs avert the dissociation of GDP from the G-proteins, thereby keeping them in the inactive conformation (Figure 1). However, GAPs, convert the active GTP-bound to their inactive GDP-bound form by inactivating the intrinsic GTPase activity of the candidate G-proteins. The efficiency of the G-protein activation cascade depends on the relative amounts of active to inactive GTPase. The activity of GTPase can be altered either by accelerating GDP dissociation by GEFs or by inhibiting GDP dissociation by GDIs, or by accelerating GTP hydrolysis by GAPs. Any imbalance in either of the regulatory factors alters the hydrolytic cycle and physiologi- 49,57,58 cal functions in pancreatic β-cells.

23-25

Activation and deactivation cascade of small G-proteins.49

Figure 1: SMALL G-PROTEIN-RAC

Rac was first identified and implicated in cellular function with two cDNAs encoding proteins, Rac1 and Rac2.59 So far three isoforms of Rac proteins, Rac1, Rac2, and Rac3 have been identified in mammals. Both Rac1 and Rac2 share over 90% homology. Rac1 and Rac3 are extensively expressed in diverse tissues, whereas as, Rac2 is restricted to hematopoietic cells. Rac1 and other small G-proteins, Cdc42 and Arf6 have been recognized as key regulatory molecules in vesicle trafficking and organelle dynamics coupled with proliferation and survival of a 19,49 cell. In addition, Rac1 has also been shown to play a vital role in various diseased states including cancer and neurologi- 60-62 63 57,58 cal disorders, liver fibrosis and diabetes. Furthermore, Rac1 protein has shown to be associated with GLUT4 translo- 64,65 cation in the muscle of diabetic patients. Furthermore, Rac1 has shown to play an important role in wound healing, bacterial clearance and cell adhesion/migration by regulating actin dynamics in the gut.66 Rac1 together with cdc42 induces intestinal wound closure, mediated by N-formyl peptide receptor (FPR) stimulation leading to enhanced intestinal epithelial cell restitution.67 In addition, many pathogenic bacteria secrete factors that

trigger the posttranslational modification and activation of Rho proteins like Rac1 and cdc42 leading to gut epithelial cell death via apoptosis.68 Citalán-Madrid and group have clearly depicted the roles of small G proteins as important signaling molecules in the regulation of epithelial junctions.69 Herein this review, we describe both the positive and negative roles for Rac1 small Gprotein in islet β-cell pathophysiology.

A. Positive Role of Rac1 in Insulin Secretion: Like other small G-proteins, Rac also shuttles between inactive GDP and active GTP conformations to facilitate cellular function. These proteins undergo ADP ribosylation by C3 component of botulinum toxin prior to their association with membrane. However, potential roles for Rac1 in glucose stimulated insulin secretion (GSIS) was first demonstrated by using Clostridium difficile toxins A and B, which irreversibly monoglucosylate and inactivate specific G-proteins (Cdc42 and Rac1).32 Like Cdc42, Rac1 also undergoes posttranslational carboxymethylation and membrane translocation in the presence of stimulatory glucose concentrations. Expression of an inactive mutant of Rac1 (N17Rac1) in INS-1 cells resulted in significant morphological changes leading to inhibition of GSIS. These findings also confirmed the involvement of small G-protein Rac1 in cytoskeletal remodeling and reorganization.41 As stated above, Rac1 also requires prenylation for its function. Experiments involving pharmacological and molecular biological inhibition of Rac1 prenylation indicated marked reduction in GSIS in a variety of insulin-secreting β-cells. For an instance, GGTI-2147, a specific inhibitor for geranylgeranylation, one of the post translational modifications, significantly augmented accumulation of Rac1 in cytosol and inhibited GSIS in insulin-producing β-Cell line INS 832/13. Over expression of the regulatory α-subunit of protein prenyltransferase also attenuated glucose-induced insulin secretion in clonal pancreatic β-cells. In addition, a recent study has shown that siRNA-mediated knock down of small G-protein Rac1 attenuated GSIS significantly having no effect on the basal insulin secretion, suggesting a positive modulatory roles for Rac1 in insulin secretion.70 The importance of these small G-proteins in insulin secretion has been extensively studied in vitro; however, studies concentrating on in vivo Rac1 knock out models

Gastro

are limited. As Rac1 small G-protein is involved in many physiological processes, knocking out Rac1 might have deleterious effects. In this context, epithelial-specific Rac1-Knockout mice showed epithelial hyperplasia and a reduced basal cell layer.71 Recent study has shown that, Rac1 specific knockout in pancreatic β-cells has no difference in either β-cell mass or pancreatic islet density explaining the possible compensatory mechanisms by other Rho-GTPases.72 However, glucose stimulated insulin secretion was attenuated in these mice lacking Rac1 in β-cells both in vivo and in isolated islets. Furthermore, Rac1-null mice [βRac1−/−] exhibited impaired glucose tolerance and hypoinsulinemia, suggesting key regulatory roles for Rac1 in normal insulin function.43 Taken together, these evidences suggest a positive role for Rac1 protein in islet function.

Rac1-Nox Signaling In Insulin Secretion

Recent evidence suggests that NADPH oxidase derived tonic increase in reactive oxygen species (ROS) is required for 50,73-76 glucose stimulated insulin secretion. NADPH oxidase (Nox) represent a group of superoxide-generating enzymes which transport electrons through membranes and catalyze the cytosolic NADPH-dependent reduction of molecular oxygen to O2 •-.77 Till date, seven Nox family members have been identified i.e., Nox1, Nox2, Nox3, Nox4, Nox5, DUOX1 and DUOX2.78 The Phagocytic Nox is a multicomponent enzyme complex, composed of membrane components [catalytic glycosylated gp91 and the regulatory non-glycosylated p22 ], phox phox phox cytosolic proteins [p47 , p67 , p40 ] and a small GTPase, Rac ½.78 Activation of Nox requires translocation of cytosolic phox components to the membrane and association with gp91phox/ phox 79 p22 complex (Figure 2). Furthermore, Nox1 is the first hophox mologue of gp91phox to be described and requires small GTPase 80-83 Rac for activation. In contrast to Nox1, 2 and 3, Nox4 is a constitutively active enzyme and is activated without the necessity for GTPase Rac or the cytosolic components.84

In this setting, the functional activation of Rac1 has shown to be critical in holoenzyme assembly and activation of 78,85-88 Nox. In support of this, Gorzalczany and associates have

shown the activation of Nox and subsequent generation of ROS by targeting Rac1 to the membrane fraction.89 They also demonstrated that prenylated Rac1 but not the unprenylated form binds to the phagocyte membrane more efficiently to facilitate the superoxide generation. Along these lines, Pi and Collins have overviewed the existing evidence in supporting “secondary messenger” roles of ROS in physiological insulin secretion.50 In addition, studies have also emphasized roles for Nox in physiological insulin secretion. For example, Diphenyleneiodonium [DPI], a selective inhibitor of Nox, inhibited glucose-induced Nox activity and GSIS.75 These observations were further confirmed by Morgan and associates suggesting that DPI or p47phox antisense-induced inhibition of Nox attenuated GSIS under static or perifusion conditions.90 Graciano and co-workers demonstrated regulatory roles for Nox in palmitate-induced superoxide generation and insulin secretion in rat islets.50 Furthermore, recent findings suggests that prenylation and activation of Rac1 are critical for glucose- and mitochondrial fuel-induced Noxdependent ROS generation in clonal pancreatic β-cells and rodent islets.91 In summary, a tonic increase in intracellular ROS is necessary for normal physiological insulin secretion and Rac1 initiates subsequent signaling steps including Nox activation and insulin release.92

B. RAC1-Nox Signaling and Metabolic Dysfunction: In addi-

tion to the above described beneficial roles for Rac1 in Noxmediated ROS signaling in islet function, recent evidence also confirmed negative roles for ROS in islet β-cell dysfunction.91 Excessive ROS generation is considered central to the development of diabetes and its associated complications. Under normal physiological conditions, generation of free radicals is relatively low; however increased levels of circulating glucose promote intracellular accumulation of superoxides leading to metabolic dysfunction. Although, mitochondria remain the primary source for free radicals, emerging evidence implicates Nox as one of the major sources of extra-mitochondrial ROS. Immunological localization and functional regulation of Nox have been described in clonal β-cells, rat and human islets. Studies by Shen and associates in cardiac myocytes have also suggested regulatory roles for Rac1 in the activation of Nox and associated generation of ROS in animal models of diabetes.93 In addition, significant increase in Nox-mediated oxidative stress and subsequent metabolic dysfunction has been clearly reviewed in a recent article by Kowluru.70 However, very little is known with regard to regulatory roles of Rac1 in the holoenzyme assembly and activation of Nox in islet β-cells following chronic exposure to glucose, saturated fatty acids or cytokines.

In this context, recent findings demonstrated that prenylation of Rac1 is necessary for glucose-induced Nox activation and ROS generation in isolated β-cells. In addition, studies have also implicated Nox in metabolic dysfunction of the islet β-cell under conditions of glucolipotoxicity and exposure to cy- 57,94 tokines. Generation of ROS under these conditions appears to be largely due to the activation of Nox, since inhibition of

Gastro

phox Nox [e.g., DPI, apocynin or siRNA-p47phox] or Rac1 activation [e.g., GGTI-2147, NSC23766] markedly attenuated deleterious effects on pancreatic β-cells. In addition, the activation status of Rac1 was shown to be under precise control of Tiam1, a known guanine nucleotide exchange factor for Rac1, but not Cdc42 and Rho G-proteins in isolated β-cells.95 In further support of this, a marked reduction in high glucose-, high palmitate- cytokineinduced Rac1 and Nox activation and ROS generation in isolated β-cells was observed following treatment with NSC23766, 57,94 a selective inhibitor of Tiam1/Rac1 signaling axis. Using selective inhibitors of protein prenylation, Subasinghe, et al. phox demonstrated a critical requirement of prenylation of Rac1 for Nox-mediated β-cell dysfunction.94

Taken together, these in vitro findings clearly implicate participatory roles of Nox in exerting effects at the mitochondrial level including loss in membrane potential, cytochrome C release and activation of caspase-3 culminating in islet β-cell 94,96 dysfunction. In addition, recent studies from Sidarala and colleagues present the evidence that the Rac1-Nox2 signaling is vital in high glucose induced activation of stress activated kinases and loss in GSIS causing islet β-cell dysfunction.97 Despite these in vitro evidences, potential roles for Nox in islet dysfunction in animal models of type 2 diabetes are minimal. However, a recent study systematically examined the functional status of Nox in islets from Zucker Diabetic Fatty [ZDF] rat, which develops obesity, hyperinsulinemia, hyperglycemia and 91 58 a decline in β-cell function.58 These in vitro observations supported by findings in islets derived from the diabetic rodents [the ZDF rat] and diabetic human islets, form basis for the development of small molecule inhibitors for Rac1 and Nox activation in halting the metabolic defects, thereby retaining normal β-cell mass. In addition, a recent study from Zhou and colleagues also confirmed that the treatment with selective inhibitor NSC23766 attenuated Rac1 expression and oxidative stress in the pancreas in ob/ob mice.98 These findings provide insights into potential therapeutic targets and interventional modalities to prevent the 50,75,90,92 metabolic defects.

Potential Therapeutic Targets And Interventional Modalities

Based on the above discussion and published evidences, it is clear that Nox-derived reactive oxygen species have both positive and negative roles in the islet β-cell function. Targeting Nox holoenzyme complex could be beneficial in subsiding the excessive generation of ROS during oxidative stress milieu. In this context, a recent study proposed that gp91 , p47 and phox p67phox might serve as potential drug targets due to their selective association in the Nox holoenzyme complex.99 On the con- 91 phox trary, peptide inhibitors blocking Rac1/2 activation and p47 translocation might not be a good approach, since they are integral members of other NADPH oxidasecomplexes too. However, Mizrahi, et al. developed p47 -p67 -Rac1 chimera as a quintessential single molecule activator of Nox100 to study the

effects of Nox activation regulatory roles for Rac1. These observations are in agreement with the findings, where researchers have demonstrated a decrease in glucose-mediated Nox-induced ROS generation in the presence of prenylation inhibitors. Developing inhibitors for such quintessential single molecule activators might provide a novel therapeutics to minimize excessive generation of ROS Nox-mediated pancreatic β-cell dysfunction. Furthermore, an alternate approach to minimize the excessive generation of ROS is to enrich the antioxidant capacity of the islet β-cells. As reviewed by Acharya and Ghaskadbi, pancreatic islet β-cells hold a poor antioxidant defense mechanism. And counterbalancing oxidative environment by antioxidant treatment or overexpressing antioxidant enzymes might prove to be successful in regulating islet β-cell function. Indeed, such mo dalities have been shown to work efficiently both in vivo and in vitro . Along these lines, treatment with antioxidant, α-lipoic acid has been demonstrated to improve insulin sensitivity in type 2 diabetic subjects.102 Moreover, researchers have also shown that vitamin E treatment improves pancreatic physiology under diabetic state.103 Asayama, et al. found that rats deficient in vitamin E, selenium, or both had decreased insulin secretory reserves, suggesting that vitamin E status can directly affect pancreatic islet function. In a mouse model of type 2 diabetes, treatment with vitamin E combined with vitamin C and n-acetyl cysteine resulted in large number of pancreatic islets than controls.104 Furthermore, a recent study in humans has shown that, taurine affectively restored β-cell function and improved insulin sensitivity. Together these studies further highlight antioxidant therapy as one of the feasible options in attenuating excessive generation of ROS and subsequent reduction in oxidative stress environment in the islet β-cells.

In addition to the above mentioned strategies for attenuating oxidative stress, inhibitors blocking Tiam1/Rac1/Nox 57,94,106 107 signaling axis, polyphenolic extracts supplementation, stress activated kinase inhibitors, and angiotensin receptor antagonists112 have proven efficaciously to reduce oxidative stress and improve islet β-cell function.

Conclusion

Glucose stimulate insulin secretion (GSIS) involves a series of metabolic events involving interaction between a variety of signaling pathways to facilitate the transport of insulin-laden granules to the plasma membrane for fusion and subsequent insulin release. Compelling evidence supports involvement of small G-proteins like Rac1 and Cdc42 in the cytoskeletal reorganization, which is necessary for GSIS to occur. Recent findings further validate that Tiam1 represents one of the GEFs for Rac1 and that Tiam1/Rac1 signaling axis is requisite for GSIS. Nox appears to be an effector protein for Tiam1/ Rac1 signaling and that its activation leads to a tonic increase in the generation of ROS under the stimulatory conditions of glucose and fatty acids leading to insulin release. In addition to this, Tiam1/Rac1 signaling axis appears to play a vital role

Gastro

in Nox-mediated ROS generation under the duress of excessive glucose, palmitate, ceramide and cytokines culminating in oxidative stress and metabolic dysfunction of islet β-cells. Together, these findings suggest positive and negative modulatory roles for Tiam1-Rac1-Nox signaling pathway in islet function. The Figure 3 depicted below is indicative of potential effects of ROS on islet β-cells at different stages. Low levels of generated ROS have a positive effect on glucose stimulated insulin secretion, and as the levels of the ROS increases it causes detrimental ef- 101 113 fects and β-cell dysfunction. Therefore, it may be challenging to draw a line as to how much of ROS generation is beneficial for the normal function of islets as opposed to how much is bad to elicit damaging effects on the pancreatic β-cell. It is likely that - there may be a “window of opportunity” or “point of return” for

ROSROS GenerationGeneration && IsletIslet FunctionFunction

the islet β-cell to recover from the noxious effects of excessive ROS due to accelerated Tiam1-Rac1-Nox signaling pathway in

HowHow muchmuch isis tootoo much?much?

the diabetic states.

Gsisgsis

StagesStages 11 22 33 44

Figure 3. Hypothetical model for ROS generation in identifying the effects on pancreatic islet β-cells. 108-111

Conflicts Of Interest

The authors declare that they dont have any conflicts of interest or any acknowledgements for this submission.

FINANCIAL INTERESTS: None.

References

1. MalaisseWJ. Hormonal and environmental modification of islet activity. In: Steiner DF, Frankel N, eds. Handbook of physiology. New York: American Physiological Society. 1972; 237- 260
2. PrentkiMMatschinskyFM. Calcium, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev. 1987; 67: 1185-1248
3. MacDonaldMJ. Elusive proximal signals of β-cells for insulin secretion. Diabetes. 1990; 39: 1461-1466
4. LaychockSG. Glucose metabolism, second messengers and insulin secretion. Life Sci. 1990; 47: 2307-2316
5. NewgardCBMcGarryJD. Metabolic coupling factors in pancreatic beta-cell signal transduction. Annu Rev Biochem. 1995; 64: 689-719. doi: 10.1146/annurev.bi.64.070195.00335310.1146/annurev.bi.64.070195.003353 https://doi.org/10.1146/annurev.bi.64.070195.003353
6. DeeneyJTPrentkiMCorkeyBE. Metabolic control of β-cell function. Semin Cell Dev Biol. 2000; 11: 267-275. doi: 10.1006/ scdb.2000.0175
7. NewgardCBLuDJensenMV. Stimulus/secretion coupling factors in glucose-stimulated insulin secretion: insights gained from a multidisciplinary approach. Diabetes. 2002; 51(3): S389-S393. doi: 10.2337/diabetes.51.2007.S38910.2337/diabetes.51.2007.s389 https://doi.org/10.2337/diabetes.51.2007.s389
8. BerggrenPOLeibigerIB. Novel aspects on signal transduction in the pancreatic β cell. Nutr Metab Cardiovasc Dis. 2006; 16(1): S7-S10. doi: 10.1016/j.numecd.2005.11.00510.1016/j.numecd.2005.11.005 https://doi.org/10.1016/j.numecd.2005.11.005
9. MetzSA. Membrane phospholipid turnover as an intermediary step in insulin secretion.Putative roles of phospholipases in cell signaling. Am J Med. 1988; 85: 9-21
10. MetzSA. The pancreatic islet as a Rubik’s cube. Is phospholipid hydrolysis a piece of the puzzle? Diabetes. 1991; 40: 1565-1573
11. LawrenceMShaoCDuanLMcGlynnKCobbMH. The protein kinases ERK1/2 and their roles in pancreatic β cells. Acta Physiol (Oxf). 2008; 192: 11-17. doi: 10.1111/j.1748- 1716.2007.01785.x10.1111/j.1748-1716.2007.01785.x https://doi.org/10.1111/j.1748-1716.2007.01785.x
12. LangJ. Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur J Biochem. 1999; 259: 3-17. doi: 10.1046/j.1432-1327.1999.00043.x10.1046/j.1432-1327.1999.00043.x https://doi.org/10.1046/j.1432-1327.1999.00043.x
13. PoitoutV. Phospholipid hydrolysis and insulin secretion: a step toward solving the Rubik’s cube. Am J Physiol Endocrinol Metab. 2008; 294: E214-E216. doi: 10.1152/ajpendo.00638.200710.1152/ajpendo.00638.2007 https://doi.org/10.1152/ajpendo.00638.2007
14. MetzSARabagliaMEPintarTJ. Selective inhibitors of GTP synthesis impede exocytotic insulin release from intact rat islets. J Biol Chem. 1992; 267: 12517-12527
15. MetzSAMeredithMRabagliaMEKowluruA. Small elevations of glucose concentration redirect and amplify the synthesis of guanosine 5-triphosphate in rat islets. J Clin Invest. 1993; 92: 872-882. doi: 10.1172/JCI11666210.1172/jci116662 https://doi.org/10.1172/jci116662
16. KomatsuMNodaMSharpGW. Nutrient augmentation of Ca2-dependent and Ca2+-independent pathways in stimulus-coupling to insulin secretion can be distinguished by their guanosine triphosphate requirements: studies on rat pancreatic GASTRO islets. Endocrinology. 1998; 139: 1172-1183
17. StraubSGJamesRFDunneMJSharpGW. Glucose augmentation of mastoparan stimulated insulin secretion in rat and human pancreatic islets. Diabetes. 1998; 47: 1053-1057. doi: 10.2337/diabetes.47.7.105310.2337/diabetes.47.7.1053 https://doi.org/10.2337/diabetes.47.7.1053
18. KowluruASeaveySELiG. Glucose- and GTP-dependent stimulation of the carboxylmethylation of Cdc42 in rodent and human pancreatic islets and pure β cells: evidence for an essential role for GTP-binding proteins in nutrient-induced insulin secretion. J Clin Invest. 1996; 98: 540-555. doi: 10.1172/ JCI118822
19. KowluruA. Regulatory roles for small G-proteins in the pancreatic β cell: lessons from models of impaired insulin secretion. Am J Physiol Endocrinol Metab. 2003; 285: E669-E684. doi: 10.1152/ajpendo.00196.200310.1152/ajpendo.00196.2003 https://doi.org/10.1152/ajpendo.00196.2003
20. WangZThurmondDC. Mechanisms of biphasic insulingranule exocytosis- roles of the cytoskeleton, small GTPases and SNARE proteins. J Cell Sci. 2009; 122: 893-903. doi: 10.1242/ jcs.034355
21. RobertsonRPSeaquistERWalsethTF. G proteins and modulation of insulin secretion. Diabetes. 1991; 40: 1-6. doi: 10.2337/diab.40.1.110.2337/diab.40.1.1 https://doi.org/10.2337/diab.40.1.1
22. SeaquistERWalsethTFRedmonJBRobertsonRP. Gprotein regulation of insulin secretion. J Lab Clin Med. 1994; 123: 338-345
23. GilmanAG. G proteins: transducers of receptor-generated signals. Annu Rev Biochem.1987; 56: 615-649. doi: 10.1146/annurev.bi.56.070187.00315110.1146/annurev.bi.56.070187.003151 https://doi.org/10.1146/annurev.bi.56.070187.003151
24. BirnbaumerL. Receptor-to-effector signaling through G proteins: roles for beta gamma dimers as well as α subunits. Cell. 1992; 71: 1069-1072. doi: 10.1016/S0092-8674(05)80056-X10.1016/s0092-8674(05)80056-x https://doi.org/10.1016/s0092-8674(05)80056-x
25. ClaphamDENeerEJ. New roles for G-protein βγ-dimers in transmembrane signaling. Nature. 1993; 365: 403-406. doi: 10.1038/365403a010.1038/365403a0 https://doi.org/10.1038/365403a0
26. TakaiYSasakiTMatozakiT. Small GTP-binding proteins. Physiol Rev. 2001; 81: 153-208
27. CaseyPJSeabraMC. Protein prenyltransferases. J Biol Chem. 1996; 271: 5289-5292. doi: 10.1074/jbc.271.10.528910.1074/jbc.271.10.5289 https://doi.org/10.1074/jbc.271.10.5289
28. Maurer-StrohSWashietlSEisenhaberF. Protein prenyltransferases. Genome Biol. 2003; 4: 212.1-212.9
29. SeabraMCReissYCaseyPJBrownMSGoldsteinJL. Protein farnesyltransferase and geranylgeranyltransferase share a common α subunit. Cell. 1991; 65: 429-434. doi: 10.1016/0092- 8674(91)90460-G10.1016/0092-8674(91)90460-g https://doi.org/10.1016/0092-8674(91)90460-g
30. FuHWCaseyPJ. Enzymology and biology of CaaX protein prenylation. Rec ProgHorm Res. 1999; 54: 315-342
31. VeluthakalRKaurHGoalstoneMKowluruA. Dominant negative-subunit of farnesyl-and geranylgeranyltransferase inhibits glucose-stimulated, but not KCl stimulated, insulin secretion in INS 832/13 cells. Diabetes. 2007; 56: 204-210. doi: 10.2337/db06-066810.2337/db06-0668 https://doi.org/10.2337/db06-0668
32. KowluruALiGRabagliaME. Evidence for differential roles of the Rho subfamily of GTP-binding proteins in glucose- and calcium-induced insulin secretion from pancreatic β cells. Biochem Pharmacol. 1997; 54: 1097-1108
33. RegazziRKikuchiATakaiYWollheimCB. The small GTP-binding proteins in the cytosol of insulin-secreting cells are complexed to GDP dissociation inhibitor proteins. J Biol Chem. 1992; 267: 17512-17519
34. KowluruARabagliaMEMuseKEMetzSA. Subcellular localization and kinetic characterization of guanine nucleotide binding proteins in normal rat and human pancreatic islets and transformed β cells. Biochim Biophys Acta. 1994; 1222: 348- 359
35. DanielSNodaMCerioneRASharpGW. A link between Cdc42 and syntaxin is involved in mastoparan stimulated insulin release. Biochemistry. 2002; 41: 9663-9671. doi: 10.1021/ bi025604p
36. KowluruAChenHQTannousM. Novel roles for the Rho subfamily of GTP-binding proteins in succinate induced insulin secretion from β TC3 cells: further evidence in support of succinate mechanism of insulin release. Endocr Res. 2003; 29: 363-376
37. NevinsAKThurmondDC. Glucose regulates the cortical actin network through modulation of Cdc42 cycling to stimulate insulin secretion. Am J Physiol Cell Physiol. 2003; 285: C698-C710. doi: 10.1152/ajpcell.00093.200310.1152/ajpcell.00093.2003 https://doi.org/10.1152/ajpcell.00093.2003
38. NevinsAKThurmondDC. A direct interaction between Cdc42 and vesicle-associated membrane protein 2 regulates SNARE-dependent insulin exocytosis. J Biol Chem. 2005; 280: 1944-1952
39. NevinsAKThurmondDC. Caveolin-1 functions as a novel Cdc42 guanine nucleotide dissociation inhibitor in pancreatic β-cells. J Biol Chem. 2006; 281: 18961-18972. doi: 10.1074/jbc. M60360420010.1074/jbc.m603604200 https://doi.org/10.1074/jbc.m603604200
40. WangZOhEThurmondDC. Glucose-stimulated Cdc42 GASTRO signaling is essential for the second phase of insulin secretion. J Biol Chem. 2007; 282: 9536-9546. doi: 10.1074/jbc. M61055320010.1074/jbc.m610553200 https://doi.org/10.1074/jbc.m610553200
41. LiJLuoRKowluruALiG. Novel regulation by Rac1 of glucose-and forskolin-induced insulin secretion in INS-1 β cell. Am J Physiol Endocrinol Metab. 2004; 286: E818-E827
42. McDonaldPVeluthakalRKaurHKowluruA. Biologically active lipids promote trafficking and membrane association of Rac1 in insulin-secreting INS832/13 cells. Am J Physiol Cell Physiol. 2007; 292: C1216-C1220. doi: 10.1152/ ajpcell.00467.2006
43. AsaharaAKidoYShigeyamaY. Rac1 regulates glucose induced insulin secretion through modulation of cytoskeletal organization in β cells. Diabetes. 2008; 57(1): A55
44. GreinerTUKesavanGStåhlbergASembH. Rac1 regulates pancreatic islet morpholgenesis. BMC Dev Biol. 2009; 9: 2. doi: 10.1186/1471-213X-9-210.1186/1471-213x-9-2 https://doi.org/10.1186/1471-213x-9-2
45. KowluruAAminR. Inhibitors of post-translational modifications of G-proteins as probes to study the pancreatic beta cell function: potential therapeutic implications. Curr Drug Targets Immune Endocr Metabol Disord. 2002; 2: 129-139. doi: 10.2174/156800802334066810.2174/1568008023340668 https://doi.org/10.2174/1568008023340668
46. LawrenceJTBirnbaumMJ. ADP-ribosylation factor 6 regulates insulin secretion through plasma membrane phosphatidylinositol 4,5-bisphosphate. Proc Natl Acad Sci. 2003; 100: 13320-13325. doi: 10.1073/pnas.223212910010.1073/pnas.2232129100 https://doi.org/10.1073/pnas.2232129100
47. GrodnitzkyJASyedNKimberMJDayTADonaldsonJGHsuWH. Somatostatin receptors signal through EFA6A-ARF6 to activate phospholipase D in clonal β-cells. J Biol Chem. 2007; 282: 13410-13418. doi: 10.1074/jbc.M70194020010.1074/jbc.m701940200 https://doi.org/10.1074/jbc.m701940200
48. HammarETomasABoscoDHalbanPA. Role of the Rho-ROCK (Rho-associated kinase) signaling pathway in the regulation of pancreatic-cell function. Endocrinology. 2009; 150: 2072-2079. doi: 10.1210/en.2008-113510.1210/en.2008-1135 https://doi.org/10.1210/en.2008-1135
49. KowluruA. Small G proteins in islet beta-cell function. Endocr Rev. 2010; 31: 52-78. 10.1210/er.2009-002210.1210/er.2009-0022 https://doi.org/10.1210/er.2009-0022
50. GracianoMFSantosLRCuriRCarpinelliAR. NAD(P)H oxidase participates in the palmitate-induced superoxide production and insulin secretion by rat pancreatic islets. J Cell Physiol. 2011; 226(4): 1110-1117. doi: 10.1002/jcp.2243210.1002/jcp.22432 https://doi.org/10.1002/jcp.22432
51. BuffaLFuchsEPietropaoloMBarrFSolimenaM. ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cells. Eur J Cell Biol. 2008; 87: 197-209. doi: 10.1016/j.ejcb.2007.11.00310.1016/j.ejcb.2007.11.003 https://doi.org/10.1016/j.ejcb.2007.11.003
52. ChanSLMonksLKGaoHDeavillePMorganNG. Identification of the monomeric G-protein, Rhes, as an efaroxanregulated protein in the pancreatic β-cell. Br J Pharmacol. 2002; 136: 31-36. doi: 10.1038/sj.bjp.070468010.1038/sj.bjp.0704680 https://doi.org/10.1038/sj.bjp.0704680
53. SharoykoVVZaitsevaIIVarsanyiM. Monomeric Gprotein, Rhes, is not an imidazolineregulated protein in pancreatic β-cells. Biochem Biophys Res Commun. 2005; 338: 1455- 1459. doi: 10.1016/j.bbrc.2005.10.14510.1016/j.bbrc.2005.10.145 https://doi.org/10.1016/j.bbrc.2005.10.145
54. TaylorJPJacksonDAMorganNGChanSL. Rhes expression in pancreatic β-cells is regulated by efaroxan in a calciumdependent process. Biochem Biophys Res Commun. 2006; 349: 809-815. doi: 10.1016/j.bbrc.2006.08.10210.1016/j.bbrc.2006.08.102 https://doi.org/10.1016/j.bbrc.2006.08.102
55. LopezJAKwanEPXieLHeYJamesDEGaisanoHY. The RalAGTPase is a central regulator of insulin exocytosis from pancreatic islet cells. J Biol Chem. 2008; 283: 17939- 17945. doi: 10.1074/jbc.M80032120010.1074/jbc.m800321200 https://doi.org/10.1074/jbc.m800321200
56. SyedIJayaramBSubasingheWKowluruA. Tiam1/ Rac1 signaling pathway mediates palmitate-induced, ceramidesensitive generation of superoxides and lipid peroxides and the loss of mitochondrial membrane potential in pancreatic betacells. Biochem Pharmacol. 2010; 80: 874-883. doi: 10.1016/j. bcp.2010.05.00610.1016/j.bcp.2010.05.006 https://doi.org/10.1016/j.bcp.2010.05.006
57. SyedIKyathanahalliCNJayaramB. Increased Phagocyte-Like NADPH Oxidase and ROS Generation in Type 2 Diabetic ZDF Rat and Human Islets. Diabetes. 2011; 60: 2843- 2852. doi: 10.2337/db11-080910.2337/db11-0809 https://doi.org/10.2337/db11-0809
58. DidsburyJWeberRFBokochGMEvansTSnydermanR. Rac, a novel ras-related family of proteins that are botulinum toxin substrates. J Biol Chem. 1989; 264(28): 16378-16382
59. WangZPedersenEBasseA. Rac1 is crucial for Rasdependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo. Oncogene. 2010; 29: 3362-3373. doi: 10.1038/onc.2010.9510.1038/onc.2010.95 https://doi.org/10.1038/onc.2010.95
60. SosaMSLopez-HaberCYangC. Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer. Mol Cell. 2010; 40: 877-892. doi: 10.1016/j. molcel.2010.11.02910.1016/j.molcel.2010.11.029 https://doi.org/10.1016/j.molcel.2010.11.029
61. Hayashi-TakagiATakakiMGrazianeN. Disruptedin-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat Neurosci. 2010; 13: 327-332. doi: 10.1038/ nn.2487
62. BoppAWartlickFHenningerCKainaBFritzG. Rac1 modulates acute and subacutegenotoxin-induced hepatic stress responses, fibrosis and liver aging. Cell Death and Disease. GASTRO
63. JeBaileyLWanonoONiuWRoesslerJRudichAKlipA. Ceramide-and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells. Diabetes. 2007; 56: 394-403. doi: 10.2337/db06-082310.2337/db06-0823 https://doi.org/10.2337/db06-0823
64. UedaSKitazawaSIshidaK. Crucial role of the small GT-Pase Rac1 in insulin-stimulated translocation of glucose transporter 4 to the mouse skeletal muscle sarcolemma. FASEB J. 2010; 24: 2254-2261. doi: 10.1096/fj.09-13738010.1096/fj.09-137380 https://doi.org/10.1096/fj.09-137380
65. IizukaMKonnoS. Wound healing of intestinal epithelialcells. World J Gastroenterol. 2011; 17: 2161-2171. doi: 10.3748/ wjg.v17.i17.2161
66. BabbinBAJesaitisAJIvanovAI. Formylpeptide receptor-1 activation enhances intestinal epithelialcell restitution through phosphatidylinositol3-kinase-dependent activation of Rac1 and Cdc42. J Immunol. 2007; 179: 8112-8121. doi: 10.4049/jimmunol.179.12.811210.4049/jimmunol.179.12.8112 https://doi.org/10.4049/jimmunol.179.12.8112
67. LemichezEAktoriesK. Hijacking of Rho GTPasesduring bacterial infection. Exp Cell Res. 2013; 319: 2329-2336. doi: 10.1016/j.yexcr.2013.04.02110.1016/j.yexcr.2013.04.021 https://doi.org/10.1016/j.yexcr.2013.04.021
68. Citalán-MadridAFGarcía-PonceAVargas-RoblesHBetanzosASchnoorM. Small GTPases of the Ras superfamily regulateintestinal epithelial homeostasis and barrierfunction via common and unique mechanisms. Tissue Barriers. 2013; 1: e26938: 1-28. doi: 10.4161/tisb.2693810.4161/tisb.26938 https://doi.org/10.4161/tisb.26938
69. KowluruA. Friendly, and not so friendly, roles of Rac1 in islet β-cell function: lessons learnt from pharmacological and molecular biological approaches. Biochem Pharmacol. 2011; 81(8): 965-975. doi: 10.1016/j.bcp.2011.01.01310.1016/j.bcp.2011.01.013 https://doi.org/10.1016/j.bcp.2011.01.013
70. BenitahSAFryeMGlogauerMWattFM. Stem cell depletion through epidermal deletion of Rac1. Science. 2005; 309: 933-935. doi: 10.1126/science.111357910.1126/science.1113579 https://doi.org/10.1126/science.1113579
71. AsaharaSShibutaniYTeruyamaK. Ras-related C3 botulinum toxin substrate 1 (RAC1) regulates glucose-stimulated insulin secretion via modulation of F-actin. Diabetologia. 2013; 56: 1088-1097. doi: 10.1007/s00125-013-2849-510.1007/s00125-013-2849-5 https://doi.org/10.1007/s00125-013-2849-5
72. PiJCollinsS. Reactive oxygen species and uncoupling protein 2 in pancreatic β-cell function. Diabetes Obes Metab. 2010; 12(2): 141-148. doi: 10.1111/j.1463-1326.2010.01269.x10.1111/j.1463-1326.2010.01269.x https://doi.org/10.1111/j.1463-1326.2010.01269.x
73. GracianoMFSantosLRCuriRCarpinelliAR. NAD(P)H oxidase participates in the palmitate-induced superoxide production and insulin secretion by rat pancreatic islets. J Cell Physiol. 2011; 226(4): 1110-1117. doi: 10.1002/jcp.2243210.1002/jcp.22432 https://doi.org/10.1002/jcp.22432
74. NewsholmePMorganDRebelatoE. Insights into the critical role of NADPH oxidase(s) in the normal and dysregudoi: 10.1007/s00125-009-1536-z10.1007/s00125-009-1536-z https://doi.org/10.1007/s00125-009-1536-z
75. OliveiraHRVerlengiaRCarvalhoCRBrittoLRCuriRCarpinelliAR. Pancreatic beta cells express phagocyte-like NADPH oxidase. Diabetes. 2003; 52: 1457-1463. doi: 10.2337/ diabetes.52.6.1457
76. PiJBaiYZhangQ. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes. 2007; 56: 1783-1791
77. KrauseKH. Tissue distribution and putative physiological function of NOX family NADPH oxidases. Jpn J Infect Dis. 2004; 57(5): S28-S29
78. GeisztM. NADPH oxidases: new kids on the block. Cardiovasc Res. 2006; 71: 289-299. doi: 10.1016/j.cardiores.2006.05.00410.1016/j.cardiores.2006.05.004 https://doi.org/10.1016/j.cardiores.2006.05.004
79. BedardKKrauseKH. The NOX family of ROS generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007; 87: 245-313. doi: 10.1152/physrev.00044.200510.1152/physrev.00044.2005 https://doi.org/10.1152/physrev.00044.2005
80. BanfiBMaturanaAJaconiS. A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science. 2000; 287(5450): 138-142. doi: 10.1126/science.287.5450.13810.1126/science.287.5450.138 https://doi.org/10.1126/science.287.5450.138
81. SumimotoHMiyanoKTakeyaR. Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun. 2005; 338: 677-686
82. ChengGDieboldBAHughesYLambethJD. Nox1-dependent reactive oxygen generation is regulated by Rac1. J Biol Chem. 2006; 281: 17718-17726. doi: 10.1074/jbc.M5127512010.1074/jbc.m51275120 https://doi.org/10.1074/jbc.m51275120
83. MartynKDFrederickLMvon LoehneysenKDinauerMCKnausUG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal. 2006; 18: 69-82. doi: 10.1016/j.cellsig.2005.03.02310.1016/j.cellsig.2005.03.023 https://doi.org/10.1016/j.cellsig.2005.03.023
84. HordijkPL. Regulation of NADPH oxidases: the role of Rac proteins. Circ Res. 2006; 98: 453-462
85. AboAPickEHallNTottyNTeahanCGSegalAW. Activation of the NADPH oxidase involves the small-GTP binding protein p21rac1. Nature. 1991; 353: 668-670. doi: 10.1038/353668a010.1038/353668a0 https://doi.org/10.1038/353668a0
86. KnausUGHeyworthPGEvansTCurnutteJTBokochGM. Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science. 1991; 254: 1512-1515. doi: 10.1126/science.166018810.1126/science.1660188 https://doi.org/10.1126/science.1660188
87. BabiorBM. NADPH oxidase: an update. Blood. 1999; 93(5): GASTRO 1464-1476
88. BorregaardNTauberAI. Subcellular localization of the human neutrophil NADPH oxidase b-cytochrome and associated flavoprotein. J Biol Chem. 1984; 259(1): 47-52
89. GorzalczanyYSigalNItanMLotanOPickE. Targeting of Rac1 to the phagocyte membrane is sufficient for the induction of NADPH oxidase assembly. J Biol Chem. 2000; 275(1): 40073-40081. doi: 10.1074/jbc.M00601320010.1074/jbc.m006013200 https://doi.org/10.1074/jbc.m006013200
90. MorganDRebelatoEAbdulkaderF. Association of NAD(P)H oxidase with glucose-induced insulin secretion by pancreatic beta-cells. Endocrinology. 2009; 150(5): 2197-2201. doi: 10.1210/en.2008-114910.1210/en.2008-1149 https://doi.org/10.1210/en.2008-1149
91. SyedIKyathanahalliCNKowluruA. Phagocyte-like NADPH oxidase generates ROS in INS 832/13 cells and rat islets: role of protein prenylation. Am J Physiol Regul Integr Comp Physiol. 2011; 300(3): R756-R762. doi: 10.1152/ajpregu.00786.201010.1152/ajpregu.00786.2010 https://doi.org/10.1152/ajpregu.00786.2010
92. UchizonoYTakeyaRIwaseM. Expression of isoforms of NADPH oxidase components in rat pancreatic islets. Life Sci. 2006; 80(2): 133-139. doi: 10.1016/j.lfs.2006.08.03110.1016/j.lfs.2006.08.031 https://doi.org/10.1016/j.lfs.2006.08.031
93. ShenELiYLiY. Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes. 2009; 58(10): 2386- 2395. doi: 10.2337/db08-061710.2337/db08-0617 https://doi.org/10.2337/db08-0617
94. SubasingheWSyedIKowluruA. Phagocyte-like NADPH oxidase promotes cytokine-induced mitochondrial dysfunction in pancreatic β-cells: evidence for regulation by Rac1. Am J Physiol Regul Integr Comp Physiol. 2011; 300: R12-R20. doi: 10.1152/ajpregu.00421.201010.1152/ajpregu.00421.2010 https://doi.org/10.1152/ajpregu.00421.2010
95. VeluthakalRMadathilparambilSVMcDonaldPOlsonLKKowluruA. Regulatory roles for Tiam1, a guanine nucleotide exchange factor for Rac1, in glucose-stimulated insulin secretion in pancreatic beta-cells. Biochem Pharmacol. 2009; 77: 101-113. doi: 10.1016/j.bcp.2008.09.02110.1016/j.bcp.2008.09.021 https://doi.org/10.1016/j.bcp.2008.09.021
96. KowluruRAKowluruAVeluthakalR. TIAM1-RAC1 signalling axis-mediated activation of NADPH oxidase-2 initiates mitochondrial damage in the development of diabetic retinopathy. Diabetologia. 2014; 57(5): 1047-1056. doi: 10.1007/ s00125-014-3194-z
97. SidaralaVVeluthakalRSyedaKVlaarCNewsholmePKowluruA. Phagocyte-like NADPH oxidase (Nox2) promotes activation of p38MAPK in pancreatic β-cells under glucotoxic conditions: evidence for a requisite role of Ras-related C3 botulinum toxin substrate 1 (Rac1). Biochem Pharmacol. 2015. doi: 10.1016/j.bcp.2015.04.00110.1016/j.bcp.2015.04.001 https://doi.org/10.1016/j.bcp.2015.04.001
98. ZhouSYuDNingS. Augmented Rac1 Expression and Activity are Associated with Oxidative Stress and Decline of β Cell Function in Obesity. Cell Physiol Biochem. 2015; 35: 2135-2148. doi: 10.1159/00037401910.1159/000374019 https://doi.org/10.1159/000374019
99. El-BennaJDangPMPérianinA. Peptide-based inhibitors of the phagocyte NADPH oxidase. Biochem Pharmacol. 2010; 80(6): 778-785. doi: 10.1016/j.bcp.2010.05.02010.1016/j.bcp.2010.05.020 https://doi.org/10.1016/j.bcp.2010.05.020
100. MizrahiABerdichevskyYCaseyPJPickE. The quintessential NADPH oxidase activator: a prenylated p47-p67-Rac1 chimera-membrane association and functional capacity. J Biol Chem. 2010; 285(33): 25485-25499. doi: 10.1074/jbc. M110.11377910.1074/jbc.m110.113779 https://doi.org/10.1074/jbc.m110.113779
101. AcharyaJDGhaskadbiSS. Islets and their antioxidant defense. Islets. 2010; 2: 225-235
102. JacobSRuusPHermannR. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic. Biol. Med. 1999; 27: 309-314. doi: 10.1016/S0891- 5849(99)00089-110.1016/s0891-5849(99)00089-1 https://doi.org/10.1016/s0891-5849(99)00089-1
103. SenaCMNunesEGomesA. Supplementation of coenzyme Q10 and alpha-tocopherol lowers glycated hemoglobin level and lipid peroxidation in pancreas of diabetic rats. Nutr. Res. 2008; 28: 113-121. doi: 10.1016/j.nutres.2007.12.00510.1016/j.nutres.2007.12.005 https://doi.org/10.1016/j.nutres.2007.12.005
104. AsayamaKKooyNWBurrIM. Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase. J. Lab. Clin. Med. 1986; 107: 459-464
105. XiaoCGiaccaALewisGF. Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and β-cell function in obese and overweight, nondiabetic men. Diabetologia. 2008; 51: 139-146. doi: 10.1007/ s00125-007-0859-x
106. VeluthakalRPalanivelRZhaoYMcDonaldPGruberSKowluruA. Ceramide induces mitochondrial abnormalities in insulin-secreting INS-1 cells: potential mechanisms underlying ceramide-mediated metabolic dysfunction of the beta cell. Apoptosis. 2005; 10: 841-850. doi: 10.1007/s10495-005-0431-410.1007/s10495-005-0431-4 https://doi.org/10.1007/s10495-005-0431-4
107. DecordeKTeissedrePLSutraTVenturaECristoJPRouanetJM. Chardonnay grape seed procyaidin extract supplementation prevents high-fat diet-induced obesity in hamsters by improving adipokine imbalance and oxidative stress markers. Mol Nutr Food Res. 2009; 53: 659-666. doi: 10.1002/ mnfr.200800165
108. KanetoHNakataniYKawamoriD. Role of oxida-GASTRO tive stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic β-cell dysfunction and insulin resistance. Int J Biochem Cell Biol. 2006; 38: 782-793. de la Rosa LC, Vrenken TE, Hannivoort RA, et al. Carbon monoxide blocks oxidative stress-induced hepatocyte apoptosis via inhibition of the p54 JNK isoform. Free Radic Biol Med. 2007; 44: 1323-1333. doi: 10.1016/j.freeradbiomed.2007.12.01110.1016/j.freeradbiomed.2007.12.011 https://doi.org/10.1016/j.freeradbiomed.2007.12.011
109. MosenHSalehiAAlmP. Defective glucose-stimulated insulin release in the diabetic Goto-Kakizaki rat coincides with reduced activity of the islet carbon monoxide signaling pathway. Endocrinology. 2005; 146: 1553-1558
110. MosenHSalehiAHenningssonRLundquistI. Nitric oxide inhibits, and carbon monoxide activates, islet acid α-glucoside hydrolase activites in parallel with glucose-stimulated insulin secretion. J Endocrinol. 2006; 190: 681-693. doi: 10.1677/joe.1.0689010.1677/joe.1.06890 https://doi.org/10.1677/joe.1.06890
111. NakayamaMInoguchiTSontaT. Increased expression of NAD(P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist. Biochem Biophys Res Commun. 2005; 332(4): 927-933. doi: 10.1016/j.bbrc.2005.05.06510.1016/j.bbrc.2005.05.065 https://doi.org/10.1016/j.bbrc.2005.05.065
112. IsmailS. Mechanisms of regulation of islet function by NADPH oxidase. Diss. Wayne State University, 2011